Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01352416

Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery

Heart; Dysfunction Postoperative, Cardiac Surgery Clinical Trial

Official title:
Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery

Clinical Trial Summary

The objective of this study is to show that ranolazine is a safe, viable and potent alternative for post-operative atrial fibrillation suppression in patients undergoing cardiac surgery

Clinical Trial Description

A single center, double blind, prospective, randomized study for patients who are scheduled for elective cardiac surgery (CABG, or valve or CABG and valve). All patients who meet criteria will be prospectively enrolled in a randomized fashion. Patients enrolled will be assigned to receive twice daily identical capsules containing either placebo or ranolazine. Study drug will be initiated 2 days before surgery. Patients will receive study drug throughout their hospitalization and be kept on it for a full 2 weeks post operatively. Patients will be seen in 2 weeks and receive a 30 day follow up contact visit. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01352416
Study type Interventional
Source William Beaumont Hospitals
Contact Patti Naismith, RN
Phone 248-898-8141
Email pnaismith@beaumonthospitals.com
Status Recruiting
Phase N/A
Start date September 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT01553617 - VolulyteTM in Cardiac Surgery Phase 4
Completed NCT01353157 - Study of the Clinical Scoring System and Cytokines for Prediction of Inflammatory Response in Major Surgery N/A
Active, not recruiting NCT02224222 - Assessment of Frailty as a Risk Factor for Cardiac and Vascular Surgery
Completed NCT01382758 - Near Infrared Spectroscopy for the Detection of Acute Kidney Injury in Children Following Cardiac Surgery N/A
Completed NCT01816581 - Oral Oxycodone After Major Cardiac Surgery Phase 4
Terminated NCT01397331 - Influence of Anesthesia on Mechanical Efficiency of Left Ventricle in Patients Undergoing Open Heart Surgery Phase 4
Completed NCT01913873 - High-sensitivity Troponin in Cardiac Surgery Phase 4
Completed NCT01289470 - Clinical Assessment of Nonin 7600 Near Infrared Spectroscopy (NIRS) Tissue Oximetry During Cardiovascular Surgery N/A
Completed NCT00468598 - The Prognostic Value of Troponin T for Long-term Outcome After Cardiac Surgery N/A
Recruiting NCT03469440 - Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery N/A
Completed NCT02371863 - Normal Values in Stress Echocardiographic Parameters in Patients After Successful Mitral Valve Repair for Organic MR N/A
Completed NCT05038267 - Femoral Venous Pulsatility and Right Heart Dysfunction in Heart Surgery: An Observational Study
Not yet recruiting NCT02524353 - Follow-up Study of Patients Undergoing Cardiac Surgery N/A
Terminated NCT02210949 - Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery Phase 4
Completed NCT01559870 - Peri-operative Prediction of Prolonged Stay in the Cardiac Intensive Care Unit for Adult Cardiac Surgery N/A
Recruiting NCT01258231 - Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Completed NCT01457898 - Non-invasive Mechanical Ventilation After Cardiac Surgery N/A